Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Effects of the adenosine A sub(2A) antagonist istradefylline on cognitive performance in rats with a 6-OHDA lesion in prefrontal cortex
by
Mori, Akihisa
, Jenner, Peter
, Kanda, Tomoyuki
, Kobayashi, Minoru
, Kadowaki Horita, Takako
in
6-Hydroxydopamine
2013
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Effects of the adenosine A sub(2A) antagonist istradefylline on cognitive performance in rats with a 6-OHDA lesion in prefrontal cortex
by
Mori, Akihisa
, Jenner, Peter
, Kanda, Tomoyuki
, Kobayashi, Minoru
, Kadowaki Horita, Takako
in
6-Hydroxydopamine
2013
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Effects of the adenosine A sub(2A) antagonist istradefylline on cognitive performance in rats with a 6-OHDA lesion in prefrontal cortex
Journal Article
Effects of the adenosine A sub(2A) antagonist istradefylline on cognitive performance in rats with a 6-OHDA lesion in prefrontal cortex
2013
Request Book From Autostore
and Choose the Collection Method
Overview
Rationale: Altered cognitive function is a common feature of both the early and later stages of Parkinson's disease (PD) that involves alterations in cortical dopamine content. Adenosine A sub(2A) antagonists, such as istradefylline, improve motor function in PD, but their effect on cognitive impairment has not been determined. Objective: The present study investigated whether impairment of working memory due to the loss of dopaminergic input into the prefrontal cortex (PFC) is reversed by administration of istradefylline. We also evaluated whether A sub(2A) antagonist administration modulates dopamine levels in the PFC. Methods: Bilateral lesions of the dopaminergic input to the PFC were produced in rats using 6-hydroxydopamine (6-OHDA). Cognitive performance was evaluated using an object recognition task and delayed alternation task. The effects of istradefylline, donepezil and methamphetamine on cognitive performance were examined. In addition, the effect of istradefylline on extracellular dopamine levels in the PFC was studied. Results: PFC dopamine levels and cognitive performance were significantly reduced by 6-OHDA lesioning. Istradefylline, donepezil and methamphetamine improved cognitive performance of PFC-lesioned rats. Istradefylline increased dopamine levels in the PFC in both normal and PFC-lesioned rats. Conclusions: PFC dopaminergic input plays an important role in working memory performance. Blockade of A sub(2A) receptors using istradefylline reverses the changes in cognitive function, and this may be due to an increase in PFC dopamine content. Adenosine A sub(2A) receptor antagonists not only improve motor performance in PD but may also lead to improved cognition.
Subject
This website uses cookies to ensure you get the best experience on our website.